Apoprotein Measurements and Their Clinical Application

This publication has 32 references indexed in Scilit:

• The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosisDependence on serum LDL levels
  Atherosclerosis, 1986
• Lipoprotein(a) as a strong indicator for cerebrovascular disease.
  Stroke, 1986
• Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction
  Atherosclerosis, 1986
• A dominant role of lipoprotein(a) in the investigation and evaluation of parameters indicating the development of cervical atherosclerosis
  Atherosclerosis, 1985
• Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease
  The American Journal of Cardiology, 1985
• Correlation of the extent of coronary occlusion with Apo B levels Application of a new enzyme immunoassay technique for Apo B
  Atherosclerosis, 1984
• Plasma apolipoprotein B and VLDL-, LDL-, and HDL- cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography
  Atherosclerosis, 1981
• Lipoprotein Lp(a) and the risk for myocardial infarction
  Atherosclerosis, 1981
• Apolipoprotein A-I, A-II and C-II in black and white residents of Evans County.
  Circulation, 1980
• The Tromsø Heart Study: Serum apolipoprotein Al concentration in relation to future coronary heart disease
  European Journal of Clinical Investigation, 1978